{"id":468,"date":"2020-06-24T09:00:17","date_gmt":"2020-06-24T00:00:17","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/?p=468"},"modified":"2020-06-24T09:37:11","modified_gmt":"2020-06-24T00:37:11","slug":"2018%e5%b9%b4%ef%bc%88%e5%b9%b3%e6%88%9030%e5%b9%b4%e5%ba%a6%ef%bc%89%e3%81%ae%e7%a0%94%e7%a9%b6%e6%a5%ad%e7%b8%be","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/achievement\/20200624468\/","title":{"rendered":"2018\u5e74\uff08\u5e73\u621030\u5e74\u5ea6\uff09\u306e\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"

A. \u8ad6\u6587<\/h3>\n

\u3010\u8457\u66f8\u3011<\/h4>\n
    \n
  1. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. 1\u7ae0 \u304c\u3093\u3068\u65e5\u5e38\u7684\u691c\u67fb 5 \u304c\u3093\u95a2\u9023\u30a6\u30a4\u30eb\u30b9\u691c\u67fb. \u304c\u3093\u306e\u81e8\u5e8a\u691c\u67fb\u30cf\u30f3\u30c9\u30d6\u30c3\u30af. \u65e5\u672c\u533b\u4e8b\u65b0\u5831\u793e. \u6771\u4eac. 2019; 26-38.<\/li>\n
  2. \u5ca1\u5c71\u662d\u5f66. \u7b2c7\u7ae0\u3000\u8840\u7403\u691c\u67fb. \u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u81e8\u5e8a\u691c\u67fb\u5024 \u7b2c2\u7248. \u6771\u4eac\u5316\u5b66\u540c\u4eba. \u6771\u4eac. 2019; 23-27.<\/li>\n<\/ol>\n

    \u3010\u539f\u8457\u3011<\/h4>\n
      \n
    1. Fukumoto T, Ikebe E, Ogata M, Kohno K, Kuramitsu M, Sato Y, Fife N, Matsumoto T, Yahiro T, Ikeda M, Kusano S, Okayama A, Hori M, Hijiya N, Tsukamoto Y, Hirashita Y, Moriyama M, Ahmed K, Hasegawa H, Nishizono A, Saito M, Iha H. Complete Sequences of the Human T-Cell Leukemia Virus Type 1 Proviral Genomes from Newly Established Adult T-Cell Leukemia Cell Lines in Oita Prefecture, Japan. Genome Announc. 2018 Jun 21;6(25) doi: 10.1128\/genomeA.00090-18.<\/li>\n
    2. \u677e\u6d66\u6210\u7f8e, \u4f50\u4f2f\u88d5\u4e8c, \u6885\u6728\u4e00\u7f8e, \u6b66\u7530\u5c55\u5e78, \u5c71\u7530\u660e\u8f1d, \u5c71\u672c\u6210\u90ce, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. C.DIFF QUIK CHEK COMPLETE?\u306b\u3066\u30af\u30ed\u30b9\u30c8\u30ea\u30b8\u30a6\u30e0\u30fb\u30c7\u30a3\u30d5\u30a3\u30b7\u30eb\u6297\u539f\uff08\u30b0\u30eb\u30bf\u30df\u30f3\u9178\u30c7\u30d2\u30c9\u30ed\u30b2\u30ca\u30fc\u30bc(GDH)\uff09\u967d\u6027\u30fb\u30c8\u30ad\u30b7\u30f3\u9670\u6027\u3092\u793a\u3057\u305f\u691c\u4f53\u306b\u304a\u3051\u308bBD\u30de\u30c3\u30af\u30b9CDIFF?\u3092\u7528\u3044\u305f\u907a\u4f1d\u5b50\u691c\u67fb\u306e\u6709\u7528\u6027. \u533b\u5b66\u691c\u67fb. 2018; 67(4): 451-455. (7\u6708)<\/li>\n
    3. \u6a4b\u5009\u60a0\u8f1d, \u6885\u6728\u4e00\u7f8e, \u732a\u5d0e\u307f\u3055\u304d, \u5c71\u7530\u660e\u8f1d, \u9ad8\u6728\u899a, \u660e\u5229\u7f8e\u91cc, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30eb\u30df\u30d1\u30eb\u30b9G1200\u3092\u7528\u3044\u305fHTLV-1\u304a\u3088\u3073HTLV-2\u6297\u4f53\u540c\u6642\u691c\u51fa\u8a66\u85ac\uff08\u30eb\u30df\u30d1\u30eb\u30b9HTLV-\u2160\/\u2161\uff09\u306e\u8a55\u4fa1. \u533b\u5b66\u691c\u67fb. 2018; 67(4): 497-502. (7\u6708)<\/li>\n
    4. \u5ca1\u5c71\u662d\u5f66, \u798f\u7530\u771f\u5f13, \u4f50\u4f2f\u88d5\u4e8c, \u9ad8\u57ce\u4e00\u90ce, \u5e73\u539f\u5eb7\u5bff. \u75c5\u9662\u5927\u898f\u6a21\u518d\u6574\u5099\u306b\u4f34\u3046\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u611f\u67d3\u4e88\u9632\u5bfe\u7b56. \u74b0\u5883\u611f\u67d3\u8a8c. 2018; 33(4): 161-168. (7\u6708)<\/li>\n
    5. Kuramitsu M, Okuma K, Nakashima M, Sato T, Sasaki D, Hasegawa H, Umeki K, Kubota R, Sasada K, Sobata R, Matsumoto C, Kaneko N, Tezuka K, Matsuoka S, Utsunomiya A, Koh KR, Ogata M, Ishitsuka K, Taki M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Watanabe T, Hamaguchi I. Value assignment of the reference material for human T-cell leukemia virus type 1 quantitative PCR in Japan. Microbiol Immunol. 2018 Aug 20. doi: 10.1111\/1348-0421.12644. [Epub ahead of print]<\/li>\n
    6. Umekita K, Hashiba Y, Kariya Y, Kubo K, Miyauchi S, Aizawa A, Umeki K, Nomura H, Kawaguchi T, Matsuda M, Takajo I, Hidaka T, Okayama A. The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study. Mod Rheumatol. 2019 ;29(5):795-801. (Sep) doi: 10.1080\/14397595.2018.1519890. Epub 2018 Oct 25.<\/li>\n
    7. Yamada A, Umeki K, Saeki Y, Hashikura Y, Nomura H, Yamamoto I, Umekita K, Takajo I, Koshimoto C, Okayama A. Detection of microbial genes in a single leukocyte by polymerase chain reaction following laser capture microdissection. Journal of Microbiological Methods. 2018; 155:42-48 (Dec)<\/li>\n
    8. Gotoh Y, Taniguchi T, Yoshimura D, Katsura K, Saeki Y, Hirabara Y, Fukuda M, Takajo I, Tomida J, Kawamura Y, Ogura Y, Itoh T, Misawa N, Okayama A, Hayashi T. Multi-step genomic dissection of a suspected intra-hospital Helicobacter cinaedi outbreak. Microb Genom. 2018; 4(12). e000236. (Dec)<\/li>\n
    9. Nomura H, Umekita K, Hashikura Y, Umeki K, Yamamoto I, Aratake Y, Saito M, Hasegawa H, Yanagihara K, Okayama A. Diversity of cell phenotypes among MT-2 cell lines affects the growth of U937 cells and cytokine production. Human Cell. 2019; 32(2): 185-192 (Apr) doi: 10.1007\/s13577-018-00231-3. Epub 2018 Dec 17<\/li>\n
    10. Kamoi K, Okayama A, Izumo S, Hamaguchi I, Uchimaru K,Tojo A, Ohno-Matsui K. Adult T-Cell Leukemia\/Lymphoma-Related Ocular Manifestations: Analysis of the First Large-Scale Nationwide Survey. Frontiers in Microbiology. 2019; 9: 3240. (Jan) published: 08 January 2019 doi: 10.3389\/fmicb.2018.03240<\/li>\n
    11. Umekita K, Miyauchi S, Nomura H, Umeki K, Okayama A. Neutrophil-derived lactoferrin induces the inflammatory responses of rheumatoid arthritis synovial fibroblasts via Toll-like receptor 4. Clin Exp Rheumatol. 2019 ;37(5):834-841(Sep-Oct) Epub 2019 Feb 11.<\/li>\n<\/ol>\n

      \u3010\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\u3011<\/h4>\n
        \n
      1. Kawaguchi T, Rikitake Y, Tsuruda T, Kawata C, Rikitake M, Iwao K, Aizawa A, Kariya Y, Matsuda M, Miyauchi S, Umekita K, Takajo I, Okayama A. Infliximab as an alternative therapy for refractory adult onset Kawasaki disease. Medicine. 2018 Oct;97(40):e12720.<\/li>\n
      2. Kimura M, Aizawa A, Miyauchi S, Hasuike S, Umekita K. Peliosis Hepatis Due to Corticosteroid in Systemic Lupus Erythematosus. Intern Med. 2019 Feb 1. doi: 10.2169\/internalmedicine.2167-18. [Epub ahead of print]<\/li>\n
      3. \u5ca9\u5c3e\u6d69\u662d, \u6885\u5317\u90a6\u5f66, \u5ca9\u5c3e\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u5ddd\u53e3\u525b, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u5b89\u771f\u7531\u7f8e, \u79cb\u5c71\u88d5, \u7247\u5ca1\u5bdb\u7ae0, \u524d\u5ddd\u548c\u4e5f, \u6d45\u7530\u7950\u58eb\u90ce, \u5ca1\u5c71\u662d\u5f66. IgG4\u95a2\u9023\u6d99\u817a\u30fb\u553e\u6db2\u817a\u708e\u306b\u8a8d\u3081\u3089\u308c\u305f\u56de\u8178\u672b\u7aef\u90e8\u306e\u9686\u8d77\u6027\u75c5\u5909. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2019;39(1): 40-48.(3\u670831\u65e5)<\/li>\n<\/ol>\n

        \u3010\u7dcf\u8aac\u3011<\/h4>\n
          \n
        1. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3\u306e\u514d\u75ab\u5b66\u7684\u6cbb\u7642\u3068HTLV-1\u611f\u67d3. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2018; 38(2): 75-79. (9\u670830\u65e5)<\/li>\n
        2. \u5ca1\u5c71\u662d\u5f66, \u9ad8\u57ce\u4e00\u90ce. \u9ebb\u75b9\u3068\u305d\u306e\u5bfe\u7b56. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c. 2018; 94: 8-13. (10\u670831\u65e5)<\/li>\n<\/ol>\n
          \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

          B. \u767a\u8868<\/h3>\n

          \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/h4>\n
            \n
          1. \u798f\u5cf6\u7406\u7d17, \u5bae\u5185\u4fca\u4e00, \u5c0f\u5c71\u5f70\u5e73, \u576a\u5185\u62e1\u4f38, \u4e2d\u5cf6\u5b5d\u6cbb, \u5b89\u500d\u5f18\u751f, \u5ca1\u5c71\u662d\u5f66, \u5c0f\u677e\u5f18\u5e78. \u6df7\u5408\u6027\u7d50\u5408\u7d44\u7e54\u75c5\u306e\u8a3a\u65ad\uff11\uff13\u5e74\u5f8c\u306b \u5168\u8eab\u6027\u5f37\u76ae\u75c7\u306e\u75c5\u614b\u304c\u9855\u5728\u5316\u3057\u305f\uff11\u4f8b. \u533b\u5b66\u751f\u30fb\u7814\u4fee\u533b\u306e\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u3053\u3068\u306f\u3058\u3081\u30002018\u4eac\u90fd. \u30dd\u30b9\u30bf\u30fc. 2018. (4\u670814\u65e5, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02, \u4eac\u90fd\u5e02\u52e7\u696d\u9928)<\/li>\n
          2. \u6cb3\u91ce\u5f69\u5b50, \u6885\u5317\u90a6\u5f66, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u591a\u767a\u6027\u7b4b\u708e\/\u76ae\u819a\u7b4b\u708e\u306b\u5408\u4f75\u3059\u308b\u6d3b\u52d5\u6027\u9593\u8cea\u6027\u80ba\u75c5\u5909\u306b\u304a\u3051\u308b\u8840\u6f3fD-dimer\u306e\u81e8\u5e8a\u7684\u610f\u7fa9\u306e\u691c\u8a0e. \u7b2c62\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc. 2018. (4\u670826-28\u65e5(26\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
          3. \u5ddd\u53e3\u525b, \u529b\u6b66\u96c4\u5e79, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u6cb3\u91ce\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6\u3067\u6539\u5584\u3057\u305f\u6210\u4eba\u767a\u75c7\u306e\u5ddd\u5d0e\u75c5. \u7b2c62\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc. 2018. (4\u670826-28\u65e5(26\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
          4. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3051\u308b\u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6\u6cbb\u7642\u306b\u304a\u3051\u308b\u30ec\u30df\u30c1\u30a7\u30c3\u30afQ?\u306e\u610f\u7fa9. \u7b2c62\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u53e3\u6f14. 2018. (4\u670826-28\u65e5(27\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
          5. \u6885\u5317\u90a6\u5f66, \u6a4b\u5834\u5f25\u751f, \u4eee\u5c4b\u88d5\u7f8e, \u5bae\u5185\u4fca\u4e00, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u5ddd\u53e3\u525b, \u6cb3\u91ce\u5f69\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u65e5\u9ad8\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308bATL\u767a\u75c7\u30ea\u30b9\u30af\u56e0\u5b50\u306e\u7d4c\u6642\u7684\u5909\u5316\uff5e\u5bae\u5d0e\u770cHTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u30b3\u30db\u30fc\u30c8\u7814\u7a76\uff5e. \u7b2c62\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u53e3\u6f14. 2018. (4\u670826-28\u65e5(28\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
          6. \u5ddd\u53e3\u525b, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4\uff08SFTS\uff09\u306b\u304a\u3051\u308b\u51dd\u56fa\u80fd\u7570\u5e38. \u7b2c92\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u8b1b\u6f14\u4f1a \u7b2c66\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a\u5408\u540c\u5b66\u4f1a. \u53e3\u6f14, 2018. (5\u670831-6\u67082\u65e5(31\u65e5\u767a\u8868), \u5ca1\u5c71\u770c\u5ca1\u5c71\u5e02, \u5ca1\u5c71\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          7. \u9ad8\u57ce\u4e00\u90ce, \u5ca9\u5c3e\u6d69\u662d, \u5ca1\u5c71\u662d\u5f66. \u591a\u8077\u7a2e\u591a\u90e8\u9580\u533b\u7642\u30b9\u30bf\u30c3\u30d5\u3067\u306e\u590f\u5b63\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30a2\u30a6\u30c8\u30d6\u30ec\u30a4\u30af\u5bfe\u5fdc. \u7b2c92\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u8b1b\u6f14\u4f1a \u7b2c66\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a\u5408\u540c\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc, 2018. (5\u670831-6\u67082\u65e5(1\u65e5\u767a\u8868), \u5ca1\u5c71\u770c\u5ca1\u5c71\u5e02, \u5ca1\u5c71\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc<\/li>\n
          8. \u5c71\u7530\u660e\u8f1d, \u9ad8\u57ce\u4e00\u90ce, \u5c71\u672c\u6210\u90ce, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. 16SrRNA\u907a\u4f1d\u5b50SNPs\u3092\u5229\u7528\u3057\u305fRFLP\u6cd5\u306b\u3088\u308bVibrio furnissii \u3068 Vibrio fluvialis \u3068\u306e\u9451\u5225. \u7b2c92\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u8b1b\u6f14\u4f1a \u7b2c66\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a\u5408\u540c\u5b66\u4f1a. \u53e3\u6f14, 2018. (5\u670831-6\u67082\u65e5(2\u65e5\u767a\u8868), \u5ca1\u5c71\u770c\u5ca1\u5c71\u5e02, \u5ca1\u5c71\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          9. Kawata C, Miyauchi S, Kimura M, Rikitake Y, Iwao K, Rikitake M, Aizawa A, Kawaguchi T, Kariya Y, Matsuda M, Umekita K, Takajo K, Takajo I, Okayama A. THE CLINICAL MANIFESTATIONS IN ANTI-RO52 ANTIBODY- POSITIVE PATIENTS WITH SYSTEMIC SCLEROSIS; A RETROSPECTIVE CASE CONTROL STUDY. EULAR 2018. AB0743. 2018. (6\u670813-18\u65e5, Amsterdam, Netherlands) abstract<\/li>\n
          10. \u6885\u5317\u4f73\u5b50, \u7530\u4e2d\u5f18\u4e4b, \u6885\u6728\u4e00\u7f8e, \u79cb\u5c71\u88d5, \u6728\u8107\u62d3\u9053, \u8d64\u6728\u771f\u7531\u7f8e, \u798f\u5cf6\u525b, \u5ca1\u5c71\u662d\u5f66, \u7247\u5ca1\u5bdb\u7ae0. 10\u4ee3\u5973\u6027\u306b\u767a\u75c7\u3057\u305f\u785d\u5b50\u5316\u7d22\u72b6\u816b\u760d\u69d8\u306e\u5f62\u614b\u3092\u4f34\u3063\u305f\u7532\u72b6\u817a\u4e73\u982d\u764c\u306e\u4e00\u4f8b. \u7b2c107\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a. \u30dd\u30b9\u30bf\u30fc, 2018. (6\u670821-6\u670823\u65e5(21\u65e5\u767a\u8868), \u5317\u6d77\u9053\u672d\u5e4c\u5e02, \u30ed\u30a4\u30c8\u30f3\u672d\u5e4c\u3001\u30cb\u30c8\u30ea\u6587\u5316\u30db\u30fc\u30eb)<\/li>\n
          11. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306e\u598a\u5a20\u30fb\u51fa\u7523. \u7b2c56\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u53e3\u6f14 2018. (9\u67081-9\u67082\u65e5(1\u65e5\u767a\u8868), \u4f50\u8cc0\u770c\u4f50\u8cc0\u5e02, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c7\u306f\u304c\u304f\u308c)<\/li>\n
          12. \u6728\u6751\u8ce2\u4fca, \u5ca9\u5c3e\u6d69\u662d\u3001\u5ddd\u53e3\u525b, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u771f\u592e, \u6cb3\u91ce\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30af\u30ea\u30aa\u30b0\u30ed\u30d6\u30ea\u30f3\u8840\u75c7\u6027\u8840\u7ba1\u708e\u3092\u5408\u4f75\u3057\u305f\uff4c\uff47G4\u95a2\u9023\u75be\u60a3\u306e1\u4f8b. \u30dd\u30b9\u30bf\u30fc. \u7b2c56\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2018. (9\u67081-9\u67082\u65e5(2\u65e5\u767a\u8868), \u4f50\u8cc0\u770c\u4f50\u8cc0\u5e02, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c7\u306f\u304c\u304f\u308c)<\/li>\n
          13. \u5009\u5149\u7403, \u5927\u9688\u548c, \u5185\u4e38\u85ab, \u5c71\u91ce\u5609\u4e45, \u9577\u8c37\u5ddd\u5bdb\u96c4, \u91ce\u5742\u751f\u90f7, \u5ca1\u5c71\u662d\u5f66, \u4e45\u4fdd\u7530\u9f8d\u4e8c, \u4f50\u7af9\u6b63\u535a, \u91d1\u5b50\u7d00\u7ae0, \u6e21\u9089\u4fca\u6a39, \u6d5c\u53e3\u529f. HTLV-1\u5b9a\u91cfPCR\u306e\u6a19\u6e96\u5316\u306e\u305f\u3081\u306e\u53c2\u7167\u54c1\u306e\u4f5c\u88fd. \u7b2c5\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u53e3\u6f14, 2018. (8\u670831-9\u67082\u65e5(2\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u4e00\u6a4b\u8b1b\u5802)<\/li>\n
          14. \u91ce\u5742\u751f\u90f7, \u5ca9\u6c38\u6b63\u5b50, \u5ca1\u5c71\u662d\u5f66, \u4eca\u6cc9\u82b3\u5b5d, \u6e21\u9089\u4fca\u6a39, \u5185\u4e38\u85ab, \u585a\u5d0e\u90a6\u5f18. ATL\u767a\u75c7\u8005\u306e\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u5408\u4f75\u3068\u305d\u306e\u6cbb\u7642\u85ac\u306b\u95a2\u3059\u308b\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c\u5831\u544a. \u7b2c5\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u53e3\u6f14, 2018. (8\u670831-9\u67082\u65e5(2\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u4e00\u6a4b\u8b1b\u5802)<\/li>\n
          15. \u798f\u5143\u62d3\u90ce, \u6c60\u8fba\u8a60\u7f8e, \u7dd2\u65b9\u6b63\u7537, \u5e78\u91ce\u548c\u6d0b, \u5009\u5149\u7403, \u6c60\u7530\u6b63\u5fb3, \u8349\u91ce\u79c0\u4e00, \u5ca1\u5c71\u662d\u5f66, \u5800\u5149\u96c4, \u6ce5\u8c37\u76f4\u6a39, \u585a\u672c\u7fa9\u4e4b, \u5b88\u5c71\u6b63\u80e4\uff0c\u30ab\u30e0\u30eb\u30c7\u30a3\u30f3\u30a2\u30cf\u30e1\u30c9, \u9577\u8c37\u5ddd\u5bdb\u96c4, \u658e\u85e4\u76ca\u6e80, \u4f0a\u6ce2\u82f1\u514b. Complete Sequences of the HTLV-1 Proviral Genomes from Newly Established ATL cell-lines in Oita. \u7b2c5\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc, 2018. (8\u670831-9\u67082\u65e5(1\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u4e00\u6a4b\u8b1b\u5802)<\/li>\n
          16. \u6885\u6728\u4e00\u7f8e, \u6a4b\u5009\u60a0\u8f1d, \u5c71\u7530\u660e\u8f1d, \u5c71\u672c\u6210\u90ce, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. HTLV-1 pX\u9818\u57df\u306e\u5869\u57fa\u30df\u30b9\u30de\u30c3\u30c1\u306b\u3088\u308a\u30d7\u30ed\u30a6\u30a4\u30eb\u30b9\u91cf\u304c\u507d\u4f4e\u5024\u3092\u793a\u3057\u305fHTLV-1\u30ad\u30e3\u30ea\u30a2. \u7b2c5\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc, 2018. (8\u670831-9\u67082\u65e5(1\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u4e00\u6a4b\u8b1b\u5802)<\/li>\n
          17. \u6a4b\u5834\u5f25\u751f, \u5357\u5bdb\u4e4b, \u6cb3\u91ce\u6566\u5b50, \u5bae\u7530\u7fa9\u53f2, \u65e5\u9ad8\u5229\u5f66, \u9577\u5b89\u82f1\u6cbb, \u4e38\u5c71\u6cbb\u5f66, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u30b4\u30ea\u30e0\u30de\u30d6\u6cbb\u7642\u4e2d\u306b\u91cd\u75c7\u7cde\u7dda\u866b\u611f\u67d3\u3068\u8a3a\u65ad\u3057\u305fHTLV-1\u6297\u4f53\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\uff11\u4f8b. \u7b2c5\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc, 2018. (8\u670831-9\u67082\u65e5(1\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u4e00\u6a4b\u8b1b\u5802)<\/li>\n
          18. \u5c71\u7530\u660e\u8f1d, \u5c71\u8107\u5186\u83ef\uff0c\u6075\u7a1c\u4e5f, \u6b66\u7530\u5c55\u5e78, \u6885\u6728\u4e00\u7f8e, \u4f50\u4f2f\u88d5\u4e8c, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66, \u690d\u91ce\u5178\u5b50. Sneathia sanguinegenes\u306b\u3088\u308b\u5b50\u5bae\u5185\u611f\u67d3\u75c7\u306e\uff11\u4f8b. \u7b2c53\u56de\u65e5\u81e8\u6280\u4e5d\u5dde\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. \u53e3\u6f14. 2018. (10\u67086-7\u65e5\uff087\u65e5\u767a\u8868\uff09, \u5927\u5206\u770c\u5225\u5e9c\u5e02, \u5225\u5e9c\u56fd\u969b\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          19. \u6885\u6728\u4e00\u7f8e, \u6a4b\u5009\u60a0\u8f1d, \u5c71\u7530\u660e\u8f1d, \u5c71\u672c\u6210\u90ce, \u6885\u5317\u90a6\u5f66, \u5927\u9688\u548c, \u6d5c\u53e3\u529f, \u5ca1\u5c71\u662d\u5f66. Line immunoassay \u3068PCR\u6cd5\u306b\u3088\u308bHTLV-1\u611f\u67d3\u75c7\u306e\u78ba\u8a8d\u691c\u67fb\u306e\u8a55\u4fa1. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u7b2c50\u56de\u5927\u4f1a. \u53e3\u6f14. 2018. (10\u670811-13\u65e5\uff0812\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02, \u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834, \u795e\u6238\u56fd\u969b\u5c55\u793a\u5834)<\/li>\n
          20. \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u5ddd\u53e3\u525b, \u6728\u6751\u8ce2\u4fca, \u5ddd\u7530\u5343\u7d18, \u5ca9\u5c3e\u6d69\u662d, \u6cb3\u91ce\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5927\u6a4b\u5178\u7537, \u5ca1\u5c71\u662d\u5f66. \u5bae\u5d0e\u770c\u3067\u521d\u3081\u3066\u8a3a\u65ad\u3055\u308c\u305f\u30d2\u30c8\u9846\u7c92\u7403\u30a2\u30ca\u30d7\u30e9\u30ba\u30de\u75c7\u306e1\u4f8b. \u7b2c88\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c61\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c66\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u53e3\u6f14. 2018. (11\u670816-18\u65e5\uff0816\u65e5\u767a\u8868\uff09, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u304b\u3054\u3057\u307e\u770c\u6c11\u4ea4\u6d41\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          21. \u677e\u7530\u57fa\u5f18, \u6728\u6751\u8ce2\u4fca, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u5ddd\u53e3\u525b, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30a2\u30d5\u30ea\u30ab\u304b\u3089\u5e30\u56fd\u5f8c\u306e\u6025\u6027HIV\u611f\u67d3\u75c7. \u7b2c88\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c61\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c66\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u53e3\u6f14. 2018. (11\u670816-18\u65e5\uff0817\u65e5\u767a\u8868\uff09, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u304b\u3054\u3057\u307e\u770c\u6c11\u4ea4\u6d41\u30bb\u30f3\u30bf\u30fc)<\/li>\n
          22. \u5ddd\u7530\u5343\u7d18, \u9ad8\u57ce\u4e00\u90ce, \u6885\u5317\u90a6\u5f66, \u6728\u6751\u8ce2\u4fca, \u5ca9\u5c3e\u6d69\u662d, \u6cb3\u91ce\u5f69\u5b50, \u5ddd\u53e3\u525b, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u5ca1\u5c71\u662d\u5f66. MRSA\u5c3f\u8def\u6027\u6557\u8840\u75c7\u304b\u3089\u9032\u5c55\u3057\u305f\u5316\u81bf\u6027\u95a2\u7bc0\u708e\u306e1\u4f8b. \u7b2c324\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. \u53e3\u6f14. 2019. (1\u670812\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u3000\u767e\u5e74\u8b1b\u5802)<\/li>\n
          23. \u5e73\u539f\u5eb7\u5bff, \u9ad8\u57ce\u4e00\u90ce, \u4e2d\u5c71\u96c4\u8cb4, \u8352\u6b66 \u821e, \u4f50\u4f2f\u88d5\u4e8c, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u6297\u83cc\u85ac\u4f7f\u7528\u72b6\u6cc1\u306e\u8a55\u4fa1\u3068AST\u306b\u5411\u3051\u305f\u8ab2\u984c. \u7b2c34\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc, 2019. (2\u670822-23\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02, \u795e\u6238\u56fd\u969b\u5c55\u793a\u5834\u30fb\u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n
          24. \u5ca1\u5c71\u662d\u5f66. \u75c5\u9662\u518d\u6574\u5099\uff08\u5897\u6539\u7bc9\uff09\u6642\u306e\u611f\u67d3\u5bfe\u7b56. \u7b2c34\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u57fa\u8abf\u8b1b\u6f14, 2019. (2\u670822-23\u65e5(23\u65e5\u767a\u8868), \u5175\u5eab\u770c\u795e\u6238\u5e02, \u795e\u6238\u56fd\u969b\u5c55\u793a\u5834\u30fb\u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n
          25. \u6885\u5317\u90a6\u5f66. HTLV-1\u611f\u67d3\u3068\u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c30\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u53e3\u982d. 2019. (3\u67082\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
          26. \u5927\u5009\u91ce\u96bc\u58eb, \u6b66\u7530\u5c55\u5e78, \u5c71\u8107\u5186\u83ef, \u5c71\u7530\u660e\u8f1d, \u60e0\u7a1c\u4e5f, \u4f50\u4f2f\u88d5\u4e8c, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66. \u672c\u9662\u306b\u304a\u3051\u308brapid BACpro\u2161\u3092\u7528\u3044\u305f\u8840\u6db2\u57f9\u990a\u8fc5\u901f\u5831\u544a\u306e\u904b\u7528\u5b9f\u7e3e\u306b\u3064\u3044\u3066. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c30\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u53e3\u6f14. 2019. (3\u67082\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
          27. \u677e\u6d66\u6210\u7f8e, \u6a4b\u5009\u60a0\u8f1d, \u9ad8\u6728\u899a, \u732a\u5d0e\u307f\u3055\u304d, \u6cb3\u91ce\u514b\u6d77, \u5c71\u672c\u6210\u90ce, \u6885\u6728\u4e00\u7f8e, \u79cb\u6708\u6e13\u4e00, \u5ca1\u5c71\u662d\u5f66. \u975e\u30bb\u30df\u30ce\u30fc\u30de\u6027\u7e26\u9694\u539f\u767a\u6027\u80da\u7d30\u80de\u816b\u5408\u4f75\u3057\u305f\u6025\u6027\u5de8\u6838\u82bd\u7403\u6027\u767d\u8840\u75c5. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c30\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u53e3\u6f14. 2019. (3\u67082\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
          28. \u9234\u6728\u5343\u4ee3\u5b50, \u6851\u539f\u5f69, \u7530\u4e2d\u7f8e\u4e0e, \u5c3e\u65b9\u7f8e\u5e78, \u5c0f\u5c71\u5f70\u5e73, \u5c71\u672c\u6210\u90ce, \u77f3\u5ddd\u54f2\u61b2, \u5ca1\u5c71\u662d\u5f66. \u98df\u9053\u88c2\u5b54\u30d8\u30eb\u30cb\u30a2\u306b\u3088\u308a\u5f15\u304d\u8d77\u3053\u3055\u308c\u305f\u5de6\u5ba4\u4e2d\u90e8\u9589\u585e. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c30\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u53e3\u6f14. 2019. (3\u67082\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
          29. \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u5f53\u9662\u3067\u30b5\u30ea\u30eb\u30de\u30d6\u3092\u5c0e\u5165\u3057\u305f\u75c7\u4f8b\u306e\u65e9\u671f\u52b9\u679c\u767a\u73fe\u306b\u3064\u3044\u3066\u306e\u8a55\u4fa1. \u7b2c57\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u53e3\u6f14. 2019. (3\u67089-10\u65e5(9\u65e5\u767a\u8868), \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30a2\u30af\u30ed\u30b9\u798f\u5ca1)<\/li>\n
          30. \u5185\u52e2\u7531\u4f73\u5b50, \u529b\u6b66\u96c4\u5e79, \u677e\u7530\u57fa\u5f18, \u6728\u6751\u8ce2\u4fca, \u5ca9\u5c3e\u5343\u7d18, \u5ca9\u5c3e\u6d69\u662d, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u5ddd\u53e3\u525b, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30b9\u30c6\u30ed\u30a4\u30c9\u6e1b\u91cf\u4e2d\u306b\u981a\u9ac4\u75c5\u5909\u304c\u51fa\u73fe\u3057\u305f\u7d9a\u767a\u6027\u80a5\u539a\u6027\u786c\u819c\u708e. \u7b2c57\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u53e3\u6f14. 2019. (3\u67089-10\u65e5(9\u65e5\u767a\u8868), \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30a2\u30af\u30ed\u30b9\u798f\u5ca1)<\/li>\n
          31. \u5ca9\u5c3e\u6d69\u662d, \u5ddd\u53e3\u525b, \u6728\u6751\u8ce2\u4fca, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u5343\u7d18, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u4e2d\u306b\u751f\u3058\u305fPenicillium brasilianum \u611f\u67d3\u75c7. \u7b2c82\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u3000\u65e5\u672c\u7d50\u6838\u75c5\u5b66\u4f1a\u3000\u4e5d\u5dde\u652f\u90e8\u3000\u6625\u5b63\u5b66\u8853\u8b1b\u6f14\u4f1a. \u53e3\u6f14. 2019. (3\u670816\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5e02\u6c11\u30d7\u30e9\u30b6)<\/li>\n<\/ol>\n

            \u3010\u7814\u7a76\u4f1a\u767a\u8868\u3011<\/h4>\n
              \n
            1. \u5ca9\u5c3e\u6d69\u662d. \u8907\u6570\u306eDMARDs\u306b\u62b5\u6297\u6027\u306e\u3042\u308b\u8840\u7403\u6e1b\u5c11\u3092\u4f34\u3046RA\u306e\u6cbb\u7642\u65b9\u91dd\u306f? \u5bae\u5d0eRA\u6cbb\u7642\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9. 2018. (5\u670811\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
            2. \u6a4b\u5834\u5f25\u751f. \u5f53\u9662\u306b\u304a\u3051\u308b\u30a2\u30af\u30c6\u30e0\u30e9\u52b9\u679c\u4e0d\u5341\u5206\u4f8b\u306b\u5bfe\u3059\u308b\u6295\u4e0e\u9593\u9694\u77ed\u7e2e\u306e\u4f7f\u7528\u7d4c\u9a13. \u7b2c2\u56de\u5bae\u5d0e\u770c\u30a2\u30af\u30c6\u30e0\u30e9\u5b66\u8853\u8b1b\u6f14\u4f1a. \u53e3\u6f14. 2018. (5\u670818\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
            3. \u4e45\u4fdd\u548c\u7fa9. \u30a2\u30c0\u30ea\u30e0\u30de\u30d6(ADA)+\u30e1\u30c8\u30c8\u30ec\u30ad\u30b5\u30fc\u30c8(MTX)\u4f75\u7528\u3001\u5bdb\u89e3\u4f8b\u306b\u304a\u3051\u308bMTX\u7528\u91cf\u306e\u63a8\u79fb\u306b\u3064\u3044\u3066. \u5bae\u5d0eRA\u3000ExpertMeeting. \u53e3\u6f14. 2018. (6\u670822\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
            4. \u8305\u91ce\u6b63\u884c, \u529b\u6b66\u771f\u592e, \u5ddd\u53e3\u525b. \u5f53\u521d\u306f\u6025\u6027\u5fc3\u7b4b\u6897\u585e\u304c\u7591\u308f\u308c\u305f\u9ad8\u9f62\u5973\u6027\u306e\u6297SRP\u6297\u4f53\u967d\u6027\u30df\u30aa\u30d1\u30c1\u30fc. \u8305\u91ce\u6b63\u884c, \u529b\u6b66\u771f\u592e, \u5ddd\u53e3\u525b. \u7b2c15\u56de\u5148\u7aef\u533b\u7642\u30bb\u30df\u30ca\u30fc. \u53e3\u6f14. 2018. (7\u670821\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30db\u30c6\u30eb\uff2a\uff21\uff2c\u30b7\u30c6\u30a3\u5bae\u5d0e)<\/li>\n
            5. \u798f\u5cf6\u7406\u7d17, \u5bae\u5185\u4fca\u4e00. \u30dc\u30bb\u30f3\u30bf\u30f3\u5185\u670d\u306b\u3088\u308a\u624b\u6307\u6f70\u760d\u304c\u6539\u5584\u3057\u305f\u5168\u8eab\u6027\u5f37\u76ae\u75c7\u306e1\u4f8b. \u7b2c15\u56de\u5148\u7aef\u533b\u7642\u30bb\u30df\u30ca\u30fc. \u53e3\u6f14. 2018. (7\u670821\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30db\u30c6\u30eb\uff2a\uff21\uff2c\u30b7\u30c6\u30a3\u5bae\u5d0e)<\/li>\n
            6. \u5ca9\u5c3e\u6d69\u662d, \u5ddd\u53e3\u525b, \u6728\u6751\u8ce2\u4fca, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u81f4\u6b7b\u6027\u4e0d\u6574\u8108\u3092\u5408\u4f75\u3057\u305f\u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4\u306e\u4e00\u4f8b. \u7b2c1\u56deSFTS\u7814\u7a76\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u53e3\u6f14. 2018. (9\u67088-9\u65e5(9\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u65b0\u5bbf\u533a, \u56fd\u7acb\u611f\u67d3\u75c7\u7814\u7a76\u6240)<\/li>\n
            7. \u5ddd\u53e3\u525b, \u6728\u6751\u8ce2\u4fca, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4(SFTS) \u306b\u304a\u3051\u308b\u795e\u7d4c\u5b66\u7684\u7570\u5e38. \u7b2c1\u56deSFTS\u7814\u7a76\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u53e3\u6f14. 2018. (9\u67088-9\u65e5(9\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u65b0\u5bbf\u533a, \u56fd\u7acb\u611f\u67d3\u75c7\u7814\u7a76\u6240)<\/li>\n
            8. \u5ddd\u7530\u5343\u7d18, \u6885\u5317\u90a6\u5f66, \u5bae\u5185\u4fca\u4e00. HTLV-1\u95a2\u9023\u75be\u60a3\u3092\u5408\u4f75\u3057\u305f\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308bIL-6\u963b\u5bb3\u7642\u6cd5\u306e\u4f7f\u7528\u7d4c\u9a13. \u7b2c4\u56de\u5bae\u5d0e\u770cIL-6\u7814\u7a76\u4f1a. \u53e3\u6f14. 2018. (9\u670821\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30db\u30c6\u30eb\uff2a\uff21\uff2c\u30b7\u30c6\u30a3\u5bae\u5d0e)<\/li>\n
            9. \u6885\u5317\u90a6\u5f66, \u5ca9\u5c3e\u5343\u7d18, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u95a2\u9023\u75be\u60a3\u3092\u5408\u4f75\u3057\u305f\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u6cbb\u7642\u7d4c\u9a13. \u7b2c2\u56de\u4e5d\u5dde\u81a0\u539f\u75c5\u96e3\u6cbb\u6027\u75c5\u614b\u6cbb\u7642\u7814\u7a76\u4f1a. \u53e3\u6f14. 2019. (1\u670819\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30ea\u30d5\u30a1\u30ec\u30f3\u30b9\u99c5\u6771\u30d3\u30eb)<\/li>\n
            10. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f. \u4e2d\u75be\u60a3\u6d3b\u52d5\u6027\u4ee5\u4e0a\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u30a4\u30b0\u30e9\u30c1\u30e2\u30c9\u306e\u6cbb\u7642\u52b9\u679c-\u5bdb\u89e3\u9054\u6210\u3055\u305b\u308b\u56e0\u5b50\u306e\u691c\u8a0e-. \u7b2c34\u56de\u5bae\u5d0e\u770c\u30ea\u30a6\u30de\u30c1\u7814\u7a76\u4f1a \u7b2c27\u56de\u5bae\u5d0e\u30ea\u30a6\u30de\u30c1\u306e\u30b1\u30a2\u7814\u7a76\u4f1a. \u53e3\u6f14. 2019. (2\u670823\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc)<\/li>\n
            11. \u6a4b\u5834\u5f25\u751f, \u65e5\u9ad8\u5229\u5f66, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u65b0\u898fIL-6\u963b\u5bb3\u85ac\u306e\u6cbb\u7642\u52b9\u679c. \u7b2c34\u56de\u5bae\u5d0e\u770c\u30ea\u30a6\u30de\u30c1\u7814\u7a76\u4f1a \u7b2c27\u56de\u5bae\u5d0e\u30ea\u30a6\u30de\u30c1\u306e\u30b1\u30a2\u7814\u7a76\u4f1a. \u53e3\u6f14. 2019. (2\u670823\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc)<\/li>\n<\/ol>\n

              \u3010\u8b1b\u6f14\u30fb\u30bb\u30df\u30ca\u30fc\u3011<\/h4>\n
                \n
              1. \u9ad8\u57ce\u4e00\u90ce. \u611f\u67d3\u5bfe\u7b56\u306b\u3064\u3044\u3066. \u5e73\u621030\u5e74\u5ea6\u533b\u54e1\uff08\u7814\u4fee\u533b\uff09\u30aa\u30ea\u30a8\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3. 2018. (4\u67086\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u7ba1\u7406\u68df)<\/li>\n
              2. Umekita K. The impact of human T-cell leukemia virus type 1 in the pathogenesis of rheumatic diseases. Japan and Mongolia Joint Symposium on Research Collaboration. Symposium 2. 2018. ( 9 . April, Faculty of Medicine University of Miyazaki)<\/li>\n
              3. Umekita K. The involvement of HTLV-1 in the pathogenesis of rheumatic diseases. HTLV-1\u95a2\u9023\u75be\u60a3\u7279\u5225\u8b1b\u6f14\u4f1a. \u30df\u30cb\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 2. 2018. (4\u670817\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u81e8\u5e8a\u8b1b\u7fa9\u5ba4)<\/li>\n
              4. \u9ad8\u57ce\u4e00\u90ce, \u4e2d\u5c71\u96c4\u8cb4, \u8352\u6b66\u821e. \u9662\u5185\u611f\u67d3\u5bfe\u7b56. \u5e73\u621030\u5e74\u5ea6\u533b\u5b66\u79d11\u5e74\u751f \u65e9\u671f\u5927\u5b66\u75c5\u9662\u5b9f\u7fd2. 2018. (5\u670811\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              5. \u5ca1\u5c71\u662d\u5f66. \u85ac\u5264\u8010\u6027\u306b\u3064\u3044\u3066\uff08\uff21\uff2d\uff32\uff09\u5bfe\u7b56\u3092\u8003\u3048\u305f\u611f\u67d3\u75c7\u8a3a\u7642. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. \u7279\u5225\u8b1b\u6f14 2. 2018. (6\u67089\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
              6. \u5ca1\u5c71\u662d\u5f66. \u6c34\u9053\u86c7\u53e3\u6574\u6d41\u5668\u304c\u95a2\u4e0e\u3057\u305f\u3068\u8003\u3048\u3089\u308c\u305fM.paragordonae\/ M.gordonae\u306epseudo-outbreak. \u5e73\u621030\u5e74\u5ea6\u56fd\u516c\u7acb\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u611f\u67d3\u5bfe\u7b56\u5354\u8b70\u4f1a\u3000\u4e5d\u5dde\u30fb\u6c96\u7e04\u5730\u533a\u30d6\u30ed\u30c3\u30af\u5225\u7814\u4fee\u4f1a. \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0. 2018. (7\u67085\u65e5-6\u65e5(5\u65e5\u767a\u8868), \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              7. \u9ad8\u57ce\u4e00\u90ce, \u4e2d\u5c71\u96c4\u8cb4, \u8352\u6b66\u821e. \u57fa\u672c\u7684\u81e8\u5e8a\u624b\u6280\u300c\u885b\u751f\u7684\u624b\u6d17\u3044\u300d. \u5e73\u621030\u5e74\u5ea6\u533b\u5b66\u79d14\u5e74\u751f\u81e8\u5e8a\u8a3a\u65ad\u5b66(\u5b9f\u7fd2) 2018. (7\u67089\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u30db\u30fc\u30eb)<\/li>\n
              8. \u5ca1\u5c71\u662d\u5f66. \u4e0d\u660e\u71b1\u306e\u8a3a\u65ad\u3068\u691c\u67fb. \u65e5\u672c\u96fb\u5b50\u81e8\u5e8a\u691c\u67fb\u30bb\u30df\u30ca\u30fc in \u9577\u5d0e. 2018. (7\u670820\u65e5, \u9577\u5d0e\u770c\u9577\u5d0e\u5e02, \u30b6\u30fb\u30db\u30c6\u30eb\u9577\u5d0eBW\u30d7\u30ec\u30df\u30a2\u30b3\u30ec\u30af\u30b7\u30e7\u30f3)<\/li>\n
              9. \u5ca1\u5c71\u662d\u5f66. \u611f\u67d3\u75c7\u3068\u6613\u611f\u67d3\u6027. \u5e73\u621030\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2018. (8\u67083\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              10. \u9ad8\u57ce\u4e00\u90ce. \u75c5\u9662\u3067\u554f\u984c\u3068\u306a\u308b\u8010\u6027\u83cc. H30\u5e74\u5ea6\u770b\u8b77\u90e8\u73fe\u4efb\u6559\u80b2\u300c\u30a4\u30f3\u30d5\u30a7\u30af\u30b7\u30e7\u30f3\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u300d. 2018. (9\u67087\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              11. \u9ad8\u57ce\u4e00\u90ce. \u8077\u696d\u611f\u67d3\u9632\u6b62\u5bfe\u7b56(\uff14\u7a2e\u30a6\u30a4\u30eb\u30b9\u3001\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6). H30\u5e74\u5ea6\u770b\u8b77\u90e8\u73fe\u4efb\u6559\u80b2\u300c\u30a4\u30f3\u30d5\u30a7\u30af\u30b7\u30e7\u30f3\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u300d. 2018. (9\u67087\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              12. \u9ad8\u57ce\u4e00\u90ce. JICA TRAINING. 2018. (9\u670825\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              13. \u9ad8\u57ce\u4e00\u90ce. \u8077\u696d\u611f\u67d3\u9632\u6b62\u5bfe\u7b56(\u7d50\u6838, HIV, HBV). H30\u5e74\u5ea6\u770b\u8b77\u90e8\u73fe\u4efb\u6559\u80b2\u300c\u30a4\u30f3\u30d5\u30a7\u30af\u30b7\u30e7\u30f3\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u300d. 2018. (9\u670828\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              14. \u9ad8\u57ce\u4e00\u90ce. \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u3068\u3046\u307e\u304f\u4ed8\u304d\u5408\u3046\u305f\u3081\u306b. \u30ea\u30a6\u30de\u30c1\u533b\u7642\u8b1b\u6f14\u4f1a(\u5ef6\u5ca1\u5e02). 2018. (10\u670814\u65e5, \u5bae\u5d0e\u770c\u5ef6\u5ca1\u5e02, \u5ef6\u5ca1\u5e02\u793e\u4f1a\u6559\u80b2\u30bb\u30f3\u30bf\u30fc)<\/li>\n
              15. \u5ca1\u5c71\u662d\u5f66. \u9662\u5185\u611f\u67d3\u5bfe\u7b56\uff1a\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\u30b9. \u5e73\u621030\u5e74\u5ea6\u7b2c4\u56de\u3000\u533b\u7642\u5b89\u5168\u7ba1\u7406\u30fb\u611f\u67d3\u5bfe\u7b56\u8b1b\u6f14\u4f1a. 2018. (11\u67086\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              16. \u9ad8\u57ce\u4f73\u4eba\u5b50. \u95a2\u7bc0\u30a8\u30b3\u30fc\u30cf\u30f3\u30ba\u30aa\u30f3\u30bb\u30df\u30ca\u30fc \u5b9f\u6280\u30c8\u30ec\u30fc\u30ca\u30fc. \u5bae\u5d0e\u95a2\u7bc0\u30a8\u30b3\u30fc\u30cf\u30f3\u30ba\u30aa\u30f3\u30bb\u30df\u30ca\u30fc. 2019. (1\u670825\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5e02\u6c11\u306e\u68ee\u75c5\u9662\u3000\u7dcf\u5408\u5065\u8a3a\u30bb\u30f3\u30bf\u30fc)<\/li>\n<\/ol>\n

                \u3010\u305d\u306e\u4ed6\u3011<\/h4>\n
                  \n
                1. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66, \u5ddd\u4e0a\u7d14. HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u8cc7\u3059\u308b\u30a8\u30d3\u30c7\u30f3\u30b9\u5275\u51fa. \u5e73\u621030\u5e74\u5ea6\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb\u7814\u7a76\u8cbb\u300cHAM\u30fbHTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u8cc7\u3059\u308b\u7d71\u5408\u7684\u30ec\u30b8\u30b9\u30c8\u30ea\u306e\u69cb\u7bc9\u306b\u3088\u308b\u30a8\u30d3\u30c7\u30f3\u30b9\u306e\u5275\u51fa\u300d\u5c71\u91ce\u73ed\u30a8\u30d3\u30c7\u30f3\u30b9\u3000\u7b2c1\u56de\u73ed\u4f1a\u8b70. HTLV-1\u967d\u6027\u30ea\u30a6\u30de\u30c1\u75be\u60a3\u30ec\u30b8\u30b9\u30c8\u30ea(\u5bae\u5d0e\u30fb\u9577\u5d0e\u30b3\u30db\u30fc\u30c8)\u306e\u6982\u8981. 2018. (6\u670817\u65e5, \u9e7f\u5150\u5cf6\u770c\u59f6\u826f\u5e02,\u30d5\u30a9\u30f3\u30bf\u30ca\u306e\u4e18\u304b\u3082\u3046)<\/li>\n
                2. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u8005\u304a\u3088\u3073\u95a2\u9023\u75be\u60a3\u60a3\u8005\u306b\u5408\u4f75\u3059\u308b\u708e\u75c7\u6027\u75be\u60a3\u306e\u708e\u75c7\u4fc3\u9032\u56e0\u5b50\u306e\u63a2\u7d22. \u81e8\u5e8a\u30b2\u30ce\u30e0\u60c5\u5831\u7d71\u5408\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u6574\u5099\u4e8b\u696d\u3000\u300c\u30d2\u30c8\u3068\u30a6\u30a4\u30eb\u30b9\u306e\u30b2\u30ce\u30e0\u60c5\u5831\u3068\u81e8\u5e8a\u60c5\u5831\u306e\u7d71\u5408\u306b\u3088\u308bHTLV-1\u95a2\u9023\u75be\u60a3\u306e\u8a3a\u7642\u652f\u63f4\u5168\u56fd\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u78ba\u7acb\u300d\u30b5\u30a4\u30c8\u30d3\u30b8\u30c3\u30c8. 2018. (8\u670828\u65e5, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02,\u4eac\u90fd\u5927\u5b66\u30b2\u30ce\u30e0\u533b\u5b66\u30bb\u30f3\u30bf\u30fc)<\/li>\n
                3. \u5ca1\u5c71\u662d\u5f66, \u6885\u5317\u90a6\u5f66\u3001\u5ddd\u4e0a\u7d14, \u4e2d\u6751\u82f1\u6a39. \u300cHTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u8a3a\u7642\u306e\u624b\u5f15\u304d(Q\uff06A)\u300d\u7b2c2\u7248\u6848\u3000\u4f5c\u6210\u306b\u3064\u3044\u3066. \u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1\u3000\u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696dHAM\u306a\u3089\u3073\u306bHTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306b\u95a2\u3059\u308b\u56fd\u969b\u7684\u306a\u7dcf\u610f\u5f62\u6210\u3092\u8e0f\u307e\u3048\u305f\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306e\u4f5c\u6210\uff08HTLV\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u73ed\uff09\u7b2c2\u56de\u73ed\u4f1a\u8b70. 2018. (12\u67082\u65e5, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c9\u30a2\u30fc\u30af\u534a\u8535\u9580)<\/li>\n
                4. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u8005\u304a\u3088\u3073\u95a2\u9023\u75be\u60a3\u60a3\u8005\u306b\u5408\u4f75\u3059\u308b\u708e\u75c7\u6027\u75be\u60a3\u306e\u708e\u75c7\u4fc3\u9032\u56e0\u5b50\u306e\u63a2\u7d22. \u81e8\u5e8a\u30b2\u30ce\u30e0\u60c5\u5831\u7d71\u5408\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u6574\u5099\u4e8b\u696d\u3000\u300c\u30d2\u30c8\u3068\u30a6\u30a4\u30eb\u30b9\u306e\u30b2\u30ce\u30e0\u60c5\u5831\u3068\u81e8\u5e8a\u60c5\u5831\u306e\u7d71\u5408\u306b\u3088\u308bHTLV-1\u95a2\u9023\u75be\u60a3\u306e\u8a3a\u7642\u652f\u63f4\u5168\u56fd\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u78ba\u7acb\u300d\u73ed\u4f1a\u8b70. 2019. (2\u670819\u65e5, \u9e7f\u5150\u5cf6\u770c\u59f6\u826f\u5e02,\u30d5\u30a9\u30f3\u30bf\u30ca\u306e\u4e18\u304b\u3082\u3046)<\/li>\n<\/ol>\n
                  \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                  C. \u305d\u306e\u4ed6<\/h3>\n
                    \n
                  1. \u5ca1\u5c71\u662d\u5f66. \u30de\u30c0\u30cb\u611f\u67d3\u75c7\u6ce8\u610f. \u5bae\u5d0e\u65e5\u65e5\u65b0\u805e. 2018.(5\u670813\u65e5)<\/li>\n
                  2. \u9ad8\u57ce\u4e00\u90ce. \u533b\u5c40\u3001\u7814\u7a76\u5ba4\u3060\u3088\u308a\u3000\u5185\u79d1\u5b66\u8b1b\u5ea7\u514d\u75ab\u611f\u67d3\u75c5\u614b\u5b66\u5206\u91ce. \u7be0\u61f8 \u7b2c29\u53f7. 2018.(12\u670821\u65e5)<\/li>\n
                  3. \u9ad8\u57ce\u4e00\u90ce. \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u3068\u3046\u307e\u304f\u4ed8\u304d\u5408\u3046\u305f\u3081\u306b. \u306f\u307e\u3086\u3046. 2019; 63: 5-7.(1\u670830\u65e5)<\/li>\n<\/ol>\n

                     <\/p>\n

                    \u3010\u5b66\u4f1a\u4e3b\u50ac\u7b49\u3011 <\/h4>\n
                      \n
                    1. \u5ca1\u5c71\u662d\u5f66. \u5e73\u621030\u5e74\u5ea6\u56fd\u516c\u7acb\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u611f\u67d3\u5bfe\u7b56\u5354\u8b70\u4f1a\u3000\u4e5d\u5dde\u30fb\u6c96\u7e04\u5730\u533a\u30d6\u30ed\u30c3\u30af\u5225\u7814\u4fee\u4f1a\u3000\u5f53\u756a\u6821. \u5e73\u621030\u5e74\u5ea6\u56fd\u516c\u7acb\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u611f\u67d3\u5bfe\u7b56\u5354\u8b70\u4f1a\u3000\u4e5d\u5dde\u30fb\u6c96\u7e04\u5730\u533a\u30d6\u30ed\u30c3\u30af\u5225\u7814\u4fee\u4f1a. 2018. (7\u67085\u65e5-6\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
                    2. \u5ca1\u5c71\u662d\u5f66. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c30\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a \u5408\u540c\u7dcf\u4f1a\u9577. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c30\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. 2019. (3\u67082\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
                        <\/ol>\n
                          <\/ol>\n

                          –<\/p>\n

                          \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                          D. \u7279\u8a31\u51fa\u9858<\/h3>\n

                          –<\/p>\n

                          \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                          \u5185\u8a33\u6570\uff082020\u5e746\u670824\u65e5\u6642\u70b9\uff09<\/span><\/h2>\n

                          A.\u8ad6\u6587\uff1a\u8457\u66f8(2), \u539f\u8457(10), \u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09(3), \u7dcf\u8aac\uff082\uff09
                          \nB.\u767a\u8868\uff1a\u5b66\u4f1a\u767a\u8868\uff0832\uff09, \u7814\u7a76\u4f1a\u767a\u8868\uff0811\uff09, \u8b1b\u6f14\u30fb\u30bb\u30df\u30ca\u30fc\uff0816\uff09, \u305d\u306e\u4ed6\uff084\uff09
                          \nC.\u305d\u306e\u4ed6\uff083\uff09, \t\u5b66\u4f1a\u4e3b\u50ac\u7b49\uff082\uff09
                          \nD.\u7279\u8a31\u51fa\u9858\uff080\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"

                          A. \u8ad6\u6587 \u3010\u8457\u66f8\u3011 \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. 1\u7ae0 \u304c\u3093\u3068\u65e5\u5e38\u7684\u691c\u67fb 5 \u304c\u3093\u95a2\u9023\u30a6\u30a4\u30eb\u30b9\u691c\u67fb. \u304c\u3093\u306e\u81e8\u5e8a\u691c\u67fb\u30cf\u30f3\u30c9\u30d6\u30c3\u30af. \u65e5\u672c\u533b\u4e8b\u65b0\u5831\u793e. \u6771\u4eac. 2019; 26-38. \u5ca1\u5c71\u662d\u5f66. \u7b2c7\u7ae0\u3000\u8840\u7403\u691c\u67fb. \u77e5\u3063\u3066\u304a […]<\/p>\n","protected":false},"author":118,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9,11],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/468"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/users\/118"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/comments?post=468"}],"version-history":[{"count":0,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/468\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/media?parent=468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/categories?post=468"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/tags?post=468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}